Antiviral medications for pregnant women for pandemic and seasonal influenza: An economic computer model

Obstetrics and Gynecology

Volumn 114, Issue 5, 2009, Pages 971-980

  Lee, Bruce Y ^a   Bailey, Rachel R ^a   Wiringa, Ann E ^a   Assi, Tina Marie ^a   Beigi, Richard H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

ARTICLE; COMPUTER MODEL; COMPUTER SIMULATION; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG USE; ECONOMIC ASPECT; ENVIRONMENTAL EXPOSURE; HEALTH CARE COST; INFECTION RISK; INFLUENZA; INFLUENZA VIRUS; OUTCOME ASSESSMENT; PANDEMIC; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY ADJUSTED LIFE YEAR; SEASONAL VARIATION;

ANTIVIRAL AGENTS; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; DISEASE OUTBREAKS; DRUG COSTS; FEMALE; HOSPITALIZATION; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; INFLUENZA, HUMAN; MODELS, ECONOMIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; SEASONS;

EID: 73549106351     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181bdbfed     Document Type: Article

References (50)

1. Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerg Infect Dis 2008; 14:95-100.
2. Cox S, Posner SF, McPheeters M, Jamieson DJ, Kourtis AP, Meikle S. Influenza and pregnant women: hospitalization burden, United States, 1998-2002. J Womens Health (Larchmt) 2006; 15: 891-893
3. 3. Cox S, Posner SF, McPheeters M, Jamieson DJ, Kourtis AP, Meikle S. Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol 2006; 107:1315-1322 (Pubitemid 44336897)
4. 4. Beigi RH. Pandemic influenza and pregnancy: a call for preparedness planning. Obstet Gynecol 2007; 109:1193-1196 (Pubitemid 46685968)
5. Greenberg M, Jacobziner H, Pakter J, Weisl BA. Maternal mortality in the epidemic of Asian influenza, New York City, 1957. Am J Obstet Gynecol 1958; 76:897-902.
6. 6. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998; 148: 1094-1102 (Pubitemid 28562169)
7. Reid A. The effects of the 1918-1919 influenza pandemic on infant and child health in Derbyshire. Med Hist 2005; 49: 29-54.
8. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374:451-458
9. 9. Irving WL, James DK, Stephenson T, Laing P, Jameson C, Oxford JS, et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG 2000; 107:1282-1289 (Pubitemid 30736199)
10. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2008; 34:1-46.
11. Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007; 56:1-54.
12. Lu P, Bridges CB, Euler GL, Singleton JA. Influenza vaccination of recommended adult populations, U.S., 1989-2005. Vaccine 2008; 26:1786-1793
13. Behrman RE, Butler AS. Preterm birth: causes, consequences, and prevention. Washington (DC): Institute of Medicine of the National Academy of Sciences; 2006.
14. Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet 2000; 355:827-835
15. Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 1997; 337:874-880
16. Jefferson TO, Demicheli V, Deeks JJ, Rivetti D. Amantadine and rimantadine for preventing and treating influenza A in adults. The Cochrane Database of Systematic Reviews 2000, Issue 2. Art. No.: CD001169. DOI: 10.1002/14651858.CD001169.pub3.
17. Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000; 283:1016-1024
18. Braithwaite RS, Meltzer DO, King JT Jr, Leslie D, Roberts MS. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care 2008; 46:349-356
19. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992; 146:473-481
20. PDR. Red Book 2009. Montvale (NJ): Thompson Healthcare, Inc.; 2009.
21. Levit K (Thomson Reuters) SETR, Ryan K (Thomson Reuters), Elixhauser A (AHRQ). HCUP facts and figures, 2006: statistics on hospital-based care in the United States. Rockville, MD: Agency for Healthcare Research and Quality 2008.
22. Centers for Disease Control and Prevention (CDC). Economic costs of birth defects and cerebral palsy-United States, 1992. MMWR Morb Mortal Wkly Rep 1995; 44:694-699
23. 23. Nixon RM, Thompson SG. Parametric modelling of cost data in medical studies. Stat Med 2004; 23:1311-1331 (Pubitemid 38514826)
24. Thompson SG, Nixon RM. How sensitive are cost-effectiveness analyses to choice of parametric distributions? Med Decis Making 2005; 25:416-423
25. Tengs TO, Wallace A. One thousand health-related quality-oflife estimates. Med Care 2000; 38:583-637.
26. Smith KJ, Roberts MS. Cost-effectiveness of newer treatment strategies for influenza. Am J Med 2002; 113:300-307
27. Institute of Medicine of the National Academies. Preterm Birth: Causes, Consequences, and Prevention. 2006. Available at: http://www.iom.edu/CMS/3740/ 25471/35813.aspx. Retrieved July 1, 2009.
28. Jefferson T, Demicheli V, Rivetti D, Jones M, Di Pietrantoni C, Rivetti A. Antivirals for influenza in healthy adults: systematic review[published erratum appears in Lancet 2006; 367:2060]. Lancet 2006; 367:303-313
29. Jefferson TO, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V. Vaccines for preventing influenza in healthy adults. The Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.:CD001269. DOI: 10.1002/14651858. CD001269.pub3.
30. Demicheli V, Jefferson T, Rivetti D, Deeks J. Prevention and early treatment of influenza in healthy adults. Vaccine 2000; 18:957-1030.
31. Jefferson TO, Demicheli V, Di Pietrantoni C, Jones M, Rivetti D. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. The Cochrane Database of Systematic Reviews 2006, 3. Art. No.:CD001265. DOI: 10.1002/14651858.CD001265.pub2.
32. Williams JM. 2009 update in prevention, evaluation, and outpatient treatment of influenza. Curr Med Res Opin 2009; 25:817-828
33. Hartert TV, Neuzil KM, Shintani AK, Mitchel EF Jr, Snowden MS, Wood LB, et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol 2003; 189:1705-1712
34. Selai C, Rosser R. Eliciting EuroQol descriptive data and utility scale values from inpatients. A feasibility study. Pharmacoeconomics 1995; 8:147-158
35. Wilmoth JR, Shkolnikov V. The Human Mortality Database. 2008. Available at: www.mortality.org. Retrieved January 21, 2008.
36. 36. Rothberg MB, Rose DN. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis. Am J Med 2005; 118:68-77. (Pubitemid 40082461)
37. Centers for Disease Control and Prevention (CDC). Novel influenza A (H1N1) virus infections in three pregnant womenUnited States, April-May 2009 [published erratum appears in MMWR Morb Mortal Wkly Rep 2009; 58:541]. MMWR Morb Mortal Wkly Rep 2009; 58:497-500.
38. Centers for Disease Control and Prevention. Pregnant women and novel influenza A (H1N1) virus: considerations for clinicians. Available at: http://www.cdc.gov/h1n1flu/clinician-pregnant.htm. Retrieved August 19, 2009.
39. 39. Risebrough NA, Bowles SK, Simor AE, McGeer A, Oh PI. Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities. J Am Geriatr Soc 2005; 53:444-451 (Pubitemid 41623523)
40. 40. Rothberg MB, Bellantonio S, Rose DN. Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy. Ann Intern Med 2003; 139:321-329 (Pubitemid 38124587)
41. Sander B, Hayden FG, Gyldmark M, Garrison LP Jr, Postexposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK Pharmacoeconomics 2006; 24:373-386
42. Siddiqui MR, Edmunds WJ. Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic. Emerg Infect Dis 2008; 14:267-274
43. Talbird SE, Brogan AJ, Winiarski AP, Sander B. Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States. Am J Health Syst Pharm 2009; 66:469-480
44. Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 2003; 7:iii-iv, xi-xiii, 1-170.
45. Whitley RJ, Monto AS. Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. J Infect Dis 2006; 194: S133-8.
46. Burls A, Clark W, Stewart T, Preston C, Bryan S, Jefferson T, et al. Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation. Health Technol Assess 2002; 6:1-87.
47. 47. Lynd LD, Goeree R, O'Brien BJ. Antiviral agents for influenza: a comparison of cost-effectiveness data. Pharmacoeconomics 2005; 23:1083-1106 (Pubitemid 41633401)
48. 48. Mauskopf JA, Cates SC, Griffin AD, Neighbors DM, Lamb SC, Rutherford C. Cost effectiveness of zanamivir for the treatment of influenza in a high risk population in Australia. Pharmacoeconomics 2000; 17:611-620 (Pubitemid 30407885)
49. Muennig PA, Khan K Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults. Clin Infect Dis 2001; 33:1879-1885
50. Worley KC, Roberts SW, Bawdon RE. The metabolism and transplacental transfer of oseltamivir in the ex vivo human model. Infect Dis Obstet Gynecol 2008; 2008: 927574.